Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $428.3 million.

  • Bio-Techne's Other Gross PP&E Adjustments rose 791.43% to $428.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $428.3 million, marking a year-over-year increase of 791.43%. This contributed to the annual value of $458.5 million for FY2025, which is 1577.95% up from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Other Gross PP&E Adjustments is $428.3 million, which was up 791.43% from $412.3 million recorded in Q3 2025.
  • Bio-Techne's Other Gross PP&E Adjustments' 5-year high stood at $458.5 million during Q2 2025, with a 5-year trough of $275.6 million in Q3 2021.
  • Over the past 5 years, Bio-Techne's median Other Gross PP&E Adjustments value was $341.2 million (recorded in 2022), while the average stood at $355.9 million.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first surged by 2327.07% in 2021, then tumbled by 567.1% in 2023.
  • Over the past 5 years, Bio-Techne's Other Gross PP&E Adjustments (Quarter) stood at $311.7 million in 2021, then grew by 4.21% to $324.8 million in 2022, then increased by 4.44% to $339.2 million in 2023, then grew by 16.99% to $396.9 million in 2024, then increased by 7.91% to $428.3 million in 2025.
  • Its last three reported values are $428.3 million in Q4 2025, $412.3 million for Q3 2025, and $458.5 million during Q2 2025.